NCBIO held its 2022 Legislative Reception on Wednesday, June 22, at the North Carolina Museum of History in Raleigh. The event was well attended by NCBIO members who were joined by a number of state senators, including Life Science Caucus Co-Chair Sen. Mike Woodard and Sens. Lisa Barnes,... Continue Reading
Where things stand with the TRIPS waiver It’s been a while since we’ve talked about what’s going on at the WTO. Here’s the latest news — and why extending the waiver of COVID-19 vaccine IP is still a bad idea. The status: The World Trade Organization... Continue Reading
Expanding COVID IP waiver would harm small, medium enterprises, CSBA says Every member of the Council of State Bioscience Associations signed a letter to President Joe Biden expressing serious concerns with the proposed expansion of IP protections for COVID technology. In June, the... Continue Reading
Milestone Strategy's Joe Lanier and NCBIO President Laura Gunter moderate a panel comprising the chairs of the NC Life Sciences Caucus Sen. Mike Woodard, Rep. Donna White, Rep. Robert Reives and Sen. Paul Newton on Aug. 31. The co-chairs of the NC Life Sciences Caucus talked about workforce... Continue Reading
Taylor scholarship recipients Stephanie Alston, Gage Lindley and Ayonna Sawyer at the 2022 NCBIO Annual Meeting The second class of recipients of the Samuel M. Taylor Memorial Life Sciences Scholarship in the NC Community Colleges Foundation has been named. This year, five scholarships have... Continue Reading
Moderator Marlene Spritzer (Lee & Associates), Joel Gates (Azzur Group), Amy Watkins (Lincoln Harris) and Greg Capps (Longfellow Real Estate Partners) Lab Space Forum sponsors Stone Alexander and Marlene Spritzer (Lee & Associates), Joel Gates (Azzur Group), Carrie Kleinle Nye... Continue Reading
Leaders from public and private universities, businesses, nonprofits, trade associations and state government have joined forces to bring the new Advanced Research Projects Agency for Health headquarters to North Carolina. ARPA-H recently received $1 billion in inaugural funding from Congress... Continue Reading
NCBIO's John Wagner and Merck's Vinay Khanna at the June 1 NCBIO Biomanufacturers Forum Representatives of Merck and NCBIO discussed the supply-chain difficulties and issues the COVID-19 pandemic created for the bioscience industry at the quarterly NCBIO Biotech Manufacturers Forum meeting... Continue Reading
NCBIO members got an overview of the Food and Drug Administration’s regulatory environment for medical devices both during the pandemic and now at the NCBIO Medical Device Forum held May 11 at the NC Biotechnology Center. Robert Rosenthal, a partner with MED1 Ventures, moderated a panel... Continue Reading
On April 7, the Centers for Medicare and Medicaid Services held to its original decision to limit coverage of the Biogen’s Alzheimer’s disease treatment Aduhelm — along with other drugs like it — to clinical trials. Michelle McMurry-Heath, M.D., Ph.D., president and CEO of... Continue Reading
Sam Taylor The Samuel M. Taylor Memorial Scholarship Fund created by NCBIO at the North Carolina Community Colleges Foundation Inc. has exceeded $200,000 in gifts and pledges with leadership gifts coming from Alexandria Real Estate Equities, Biogen and Hatteras Venture Partners. Grifols,... Continue Reading
A high quality board of directors and valuable outside partnerships are two advantages that biotech startups would do well to cultivate, according to the expert panelists assembled for the NCBIO Emerging Company and Technology Forum held Wednesday, March 16, at the NC Biotechnology... Continue Reading
